Ayesha Ahmed Khan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ayesha Ahmed Khan has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Adnan Mannan
Department of Genetic Engineering and Biotechnology, University of Chittagong
1 shared publication - Ayan Saha
Department of Biological Sciences, Asian University for Women, Chittagong 4000, Bangladesh
1 shared publication Ehsanul Hoque
National Institute of Laboratory Medicine and Referral Centre, 1207, Dhaka, Bangladesh. , Mobile: +88-01819375563
1 shared publication- Fahmida Hoque Rimti
Affiliation Chittagong Medical College, Chittagong, Bangladesh
1 shared publication - H. M. Hamidullah Mehedi
Department of Medicine, 250 Bedded General Hospital, Chattogram, Bangladesh
1 shared publication - Harun Ur Rashid
Apollo Imperial Hospital, Chattogram
1 shared publication
Latest Publications
- Open Access
- 11 October 2026
- Published by Springer Nature in Research Square
A Four-Year Retrospective Analysis (2021–2024): The Impact of Prior Antibiotic Exposure on CRE Infection Prevalence and Antibiogram Profiles in a Tertiary Care Setting
Background. Carbapenem-resistant Enterobacteriaceae (CRE) are a critical-priority pathogen, and prior antimicrobial exposure is the principal modifiable driver of their emergence through selective pressure. Local antibiogram data are essential for rational empirical prescribing but remain scarce for the Chattogram region of Bangladesh. We examined the prevalence of CRE infection, the relationship between prior antibiotic exposure and resistance phenotype, and the antibiogram profile of isolates. Methods. In this retrospective observational study, 15,714 patients observed at a tertiary care centre between January 2021 and December 2024 were screened; 113 with microbiologically confirmed CRE infection formed the analytic cohort. Demographic, comorbidity, prior-exposure and outcome data were abstracted with a standardised questionnaire; prior exposure was defined as documented receipt of an antibiotic class within 30 days. Susceptibility was determined for 19 agents and multidrug resistance (MDR) defined per Magiorakos criteria. Prevalence was estimated with Wilson 95% confidence intervals (CI); associations were tested with the Fisher exact test and the Cochran–Armitage test for trend. Results. Period prevalence of CRE infection was 0.72% (95% CI 0.60–0.86%), or 7.19 per 1000 patients observed. Prior antibiotic exposure was near-universal (98/113, 86.7%), most often carbapenem (80.5%) and third-/fourth-generation cephalosporin (77.9%). Every exposure class was significantly associated with an MDR phenotype (all P < 0.001), and a clear dose–response gradient was observed: MDR rose from 0.0% among patients exposed to no prior class and 0.0% among those exposed to 1–2 classes, to 22.2% at 3–4 classes and 53.9% among those who had received all five (Cochran–Armitage z = 4.96, P < 0.0001). Duration of definitive therapy for the index episode was not associated with resistance (P = 0.143) or mortality (P = 0.677). Antibiogram profiling showed extensive resistance to cephalosporins and fluoroquinolones (> 84% for most agents) and to meropenem (77.1% of 48 tested), whereas colistin (81.6% susceptible) and tigecycline (88.2% susceptible) retained the greatest in-vitro activity. Overall, 31 of 106 patients with a determinate outcome died (29.2%). Conclusions. CRE infection affected approximately 7 per 1000 patients observed. Cumulative prior antibiotic exposure showed a strong, graded association with multidrug resistance, consistent with the selective-pressure hypothesis and providing direct local evidence for carbapenem-sparing empirical strategies. The antibiogram indicates that colistin and tigecycline remain the principal reserve agents in this setting, and that empirical reliance on cephalosporins or fluoroquinolones is no longer defensible.
- 11 October 2026
- Published by Springer Nature in Research Square
Open AccessA Four-Year Retrospective Analysis (2021–2024): The Impact of Prior Antibiotic Exposure on CRE Infection Prevalence and Antibiogram Profiles in a Tertiary Care Setting
Background. Carbapenem-resistant Enterobacteriaceae (CRE) are a critical-priority pathogen, and prior antimicrobial exposure is the principal modifiable driver of their emergence through selective pressure. Local antibiogram data are essential for rational empirical prescribing but remain scarce for the Chattogram region of Bangladesh. We examined the prevalence of CRE infection, the relationship between prior antibiotic exposure and resistance phenotype, and the antibiogram profile of isolates. Methods. In this retrospective observational study, 15,714 patients observed at a tertiary care centre between January 2021 and December 2024 were screened; 113 with microbiologically confirmed CRE infection formed the analytic cohort. Demographic, comorbidity, prior-exposure and outcome data were abstracted with a standardised questionnaire; prior exposure was defined as documented receipt of an antibiotic class within 30 days. Susceptibility was determined for 19 agents and multidrug resistance (MDR) defined per Magiorakos criteria. Prevalence was estimated with Wilson 95% confidence intervals (CI); associations were tested with the Fisher exact test and the Cochran–Armitage test for trend. Results. Period prevalence of CRE infection was 0.72% (95% CI 0.60–0.86%), or 7.19 per 1000 patients observed. Prior antibiotic exposure was near-universal (98/113, 86.7%), most often carbapenem (80.5%) and third-/fourth-generation cephalosporin (77.9%). Every exposure class was significantly associated with an MDR phenotype (all P < 0.001), and a clear dose–response gradient was observed: MDR rose from 0.0% among patients exposed to no prior class and 0.0% among those exposed to 1–2 classes, to 22.2% at 3–4 classes and 53.9% among those who had received all five (Cochran–Armitage z = 4.96, P < 0.0001). Duration of definitive therapy for the index episode was not associated with resistance (P = 0.143) or mortality (P = 0.677). Antibiogram profiling showed extensive resistance to cephalosporins and fluoroquinolones (> 84% for most agents) and to meropenem (77.1% of 48 tested), whereas colistin (81.6% susceptible) and tigecycline (88.2% susceptible) retained the greatest in-vitro activity. Overall, 31 of 106 patients with a determinate outcome died (29.2%). Conclusions. CRE infection affected approximately 7 per 1000 patients observed. Cumulative prior antibiotic exposure showed a strong, graded association with multidrug resistance, consistent with the selective-pressure hypothesis and providing direct local evidence for carbapenem-sparing empirical strategies. The antibiogram indicates that colistin and tigecycline remain the principal reserve agents in this setting, and that empirical reliance on cephalosporins or fluoroquinolones is no longer defensible.
- Open Access
- 17 December 2024
- Published by Springer Nature in Discover Public Health
- Vol. 21 (1) , 1-13
Cross-sectional observation of self-medication pattern among readymade garment workers in southern Bangladesh and their knowledge and practice towards antibiotic self-medication
- 17 December 2024
- Published by Springer Nature in Discover Public Health
- Vol. 21 (1) , 1-13
Open AccessCross-sectional observation of self-medication pattern among readymade garment workers in southern Bangladesh and their knowledge and practice towards antibiotic self-medication
- Open Access
Relation of vaccination with severity, oxygen requirement and outcome of COVID-19 infection in Chattogram, Bangladesh
Introduction Peoples all around the world are waiting for vaccination against COVID -19 infection. In Bangladesh, Astra-Zeneca (AZ) vaccine was provided, but patients had infections of SARS-COV-2 even after vaccination. We focused on observing the severity, oxygen requirement and outcome of the COVID-19 infected patients who took the first dose or completed the immunization regimen. Methods This is an observational study done among 174 COVID-19 patients from three COVID-19 dedicated hospitals of Chattogram, Bangladesh, who took AZ vaccines 1st dose or completed the schedule. All patients were Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) positive for COVID-19. Patients were enrolled after receiving written informed consent. Suspected cases or unwilling patients were excluded from the study. Ethical approval was granted by the CMOSH–ERB. SPSS-20 was used to analyze the information gathered. Results Among 174 vaccinated patients, 55(31.61%) completed the vaccination schedule, and 119(68.39%) took their 1st dose of the COVID-19 vaccine. Gender distributions revealed 67(38.5%) female and 107(61.5%) male got the vaccine, and 55 patients completed the full two doses, and 119 patients took the 1st dose. Most of the patients were 40 years and above. In the completed vaccination group, 33(60.0%) out of 55 in and in the first dose vaccinated group, 75(63.0%) out of 119 had a mild COVID-19, and severe and critical cases were found very minimum. Among the patients who have completed the vaccination, 32(58.2%) needed no oxygen, and who was given the first dose, 78(65%) needed no oxygen. No death occurred who completed the vaccine, and 3(2.5%) patients died who took 1st dose of the vaccine. Conclusion Vaccine provided in Bangladesh to the people so far seems safe and effective. Severe and critical COVID-19 is low, and the need for oxygen to admitted patients is less, and the death rate is minimal.
Open AccessRelation of vaccination with severity, oxygen requirement and outcome of COVID-19 infection in Chattogram, Bangladesh
Introduction Peoples all around the world are waiting for vaccination against COVID -19 infection. In Bangladesh, Astra-Zeneca (AZ) vaccine was provided, but patients had infections of SARS-COV-2 even after vaccination. We focused on observing the severity, oxygen requirement and outcome of the COVID-19 infected patients who took the first dose or completed the immunization regimen. Methods This is an observational study done among 174 COVID-19 patients from three COVID-19 dedicated hospitals of Chattogram, Bangladesh, who took AZ vaccines 1st dose or completed the schedule. All patients were Real-Time Reverse Transcription Polymerase Chain Reaction (rRT-PCR) positive for COVID-19. Patients were enrolled after receiving written informed consent. Suspected cases or unwilling patients were excluded from the study. Ethical approval was granted by the CMOSH–ERB. SPSS-20 was used to analyze the information gathered. Results Among 174 vaccinated patients, 55(31.61%) completed the vaccination schedule, and 119(68.39%) took their 1st dose of the COVID-19 vaccine. Gender distributions revealed 67(38.5%) female and 107(61.5%) male got the vaccine, and 55 patients completed the full two doses, and 119 patients took the 1st dose. Most of the patients were 40 years and above. In the completed vaccination group, 33(60.0%) out of 55 in and in the first dose vaccinated group, 75(63.0%) out of 119 had a mild COVID-19, and severe and critical cases were found very minimum. Among the patients who have completed the vaccination, 32(58.2%) needed no oxygen, and who was given the first dose, 78(65%) needed no oxygen. No death occurred who completed the vaccine, and 3(2.5%) patients died who took 1st dose of the vaccine. Conclusion Vaccine provided in Bangladesh to the people so far seems safe and effective. Severe and critical COVID-19 is low, and the need for oxygen to admitted patients is less, and the death rate is minimal.